Intragraft mRNA cytotoxic molecule expression in renal allograft recipients

J Carstens1, A Ozbay, C Tørring

  • 1Department of Renal Medicine, Skejby Hospital, Aarhus University Hospital, Aarhus, Denmark. drjc@dadlnet.dk

Transplant Immunology
|January 15, 2009
PubMed

Insights

T-cell activation biomarkers like perforin, granzyme B, and Fas ligand did not differentiate deceased from living kidney donors or predict early graft function. However, their expression was elevated in acute rejection cases.

Area of Science:

  • Nephrology
  • Immunology
  • Molecular Biology

Background:

  • Cytotoxic T-cell molecules (perforin, granzyme B, Fas ligand) are linked to renal allograft rejection.
  • Systemic inflammation in brain-dead donors may influence immune responses.

Purpose of the Study:

  • To assess if T-cell activation biomarker mRNA expression in donor kidneys distinguishes living from deceased donors.
  • To determine if these biomarkers predict primary graft function, delayed graft function, or acute rejection post-transplant.

Main Methods:

  • Real-time quantitative polymerase chain reaction was used to measure mRNA expression of perforin, granzyme B, and Fas ligand in 139 deceased and 19 living donor kidney biopsies.
  • Expression levels were correlated with allograft status, including primary function, delayed function, and acute rejection.
  • Biopsies from 78 renal allografts with dysfunction were analyzed.

Main Results:

  • No significant differences in perforin, granzyme B, or Fas ligand gene expression were found between deceased and living donor kidneys.
  • These cytotoxic molecule mRNA levels in donor kidneys did not distinguish primary allograft function or early acute rejection.
  • Significant differences in all 3 transcripts were observed between acute rejection and zero-hour samples, and between acute rejection and non-rejection samples.

Conclusions:

  • Effector molecules from cytotoxic T lymphocytes are not activated in deceased donor kidneys, and these genes do not predict the early post-transplant course.
  • While not predictive in donor kidneys, elevated expression of these cytotoxic markers is associated with established acute rejection.

Related Concept Videos

Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...